Frontlight ResearchEarly access
Trial site
Perlmutter Cancer Center NYU Langone
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 1/21 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Boston Scientific Corporation1 trial
- Icahn School of Medicine at Mount Sinai1 trial
Running trials
Active, not recruiting
Active, not recruiting
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
Site data: ClinicalTrials.govUpdated 12 Nov 2026